Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2003
03/27/2003US20030057258 Nondestructive inspection method
03/27/2003US20030057193 Method for forming a via hole, flexible wiring board using the method, and method for producing the flexible wiring board
03/27/2003US20030057109 Hydrogen sensor includes a pump cell and a measuring cell; hydrogen diffusion through the diffusion-limiting barrier is controlled by a Knudsen diffusion mechanism at higher hydrogen concentrations; use in fuel cell applications
03/27/2003US20030057108 Reduced out-of-warm-up baseline drift for chemical, electrochemical and enzyme sensors, by exposing the sensor and the calibrating solution to an elevated temperature for a given time period, and then exposing to a lower temperature
03/27/2003US20030057094 Methods and apparatus for the location and concentration of polar analytes using an alternating electric field
03/27/2003US20030056581 Apparatus and method for analyzing fluids
03/27/2003US20030056576 Method for evaluating a test fluid
03/27/2003US20030056570 Sensor for detecting inflammable gases
03/27/2003US20030056569 Device, method and use of an odor detection unit for examining and/or recording
03/27/2003US20030056568 Gas seep detection
03/27/2003US20030056567 Apparatus and method for measurement of coefficient of restitution and contact time
03/27/2003CA2708411A1 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003CA2708349A1 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003CA2476995A1 Method of detecting cellular immunity and application thereof to drugs
03/27/2003CA2472023A1 Method for evaluating a patient's biological condition
03/27/2003CA2461352A1 Use of hcv core antigen assay for screening of anti-viral compounds
03/27/2003CA2461065A1 Transductin-1 and transductin-2 and applications to hereditary deafness
03/27/2003CA2460845A1 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
03/27/2003CA2460817A1 A method for identifying effector molecules for gene network integration
03/27/2003CA2460812A1 Lipid-associated molecules
03/27/2003CA2460808A1 Immune response associated proteins
03/27/2003CA2460771A1 Method for determining the presence of bacteria resistant to cell lysing antibiotics
03/27/2003CA2460721A1 Genetic analysis for stratification of cancer risk
03/27/2003CA2460713A1 Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease
03/27/2003CA2460700A1 Asparagine hydroxylation of the cad domain of a hif protein
03/27/2003CA2460629A1 A method and kit for the measurement of the activation of basophils induced by allergen to determine hypersensitivity
03/27/2003CA2460616A1 Diagnosis and treatment of early pre-type 1 diabetes utilizing glial fibrillary acidic protein
03/27/2003CA2460568A1 Preparation of highly-purified plasma membranes
03/27/2003CA2460526A1 New landmarks and use thereof
03/27/2003CA2460317A1 Quinone reductase 2 and aldehyde dehydrogenase as therapeutic targets
03/27/2003CA2460151A1 Cytokine receptor
03/27/2003CA2460130A1 Method for detecting sepsis
03/27/2003CA2460128A1 Bbc3 gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter
03/27/2003CA2460120A1 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003CA2460073A1 Embossed test strip system
03/27/2003CA2459972A1 Differential diagnosis of disorders of iron metabolism by means of three independent parameters and recommendations for the treatment of these disorders of iron metabolism
03/27/2003CA2459761A1 Device and method for concentration and detection of pathogenic germs from blood products and/or their derivatives
03/27/2003CA2459219A1 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
03/27/2003CA2459140A1 Protein modification and maintenance molecules
03/27/2003CA2459022A1 Neurotransmission-associated proteins
03/27/2003CA2458303A1 Brain expressed cap-2 gene and protein associated with bipolar disorder
03/27/2003CA2457156A1 Clinical trial method for caries treatment agents
03/27/2003CA2453961A1 Concentration of protein and/or peptides samples
03/27/2003CA2452288A1 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
03/27/2003CA2445205A1 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor
03/27/2003CA2425784A1 Diagnostic markers for ischemia
03/27/2003CA2425781A1 Early diagnosis of stroke
03/26/2003EP1296334A2 Associative memory with matching circuit with differential amplification
03/26/2003EP1296143A2 Mass spectrometric detection of polypeptides
03/26/2003EP1296142A2 Calcium receptor active molecules
03/26/2003EP1296141A1 Biosensor
03/26/2003EP1296140A1 Method of evaluating binding activity of ligand to ligand-binding protein
03/26/2003EP1296139A1 Micro-array of organism-associated substance
03/26/2003EP1296138A1 Use of disease-associated gene
03/26/2003EP1296137A2 Dough measurement for monitoring and controlling the dough quality in automatic dough processing
03/26/2003EP1295952A2 Methods for screening for transdominant effector peptides and RNA molecules
03/26/2003EP1295947A1 Method of measuring total homocysteine
03/26/2003EP1295897A1 DNA encoding the chimpanzee prostaglandin E2 receptor EP4 subtype
03/26/2003EP1295896A1 Method for identifying or isolating a molecule and molecules identified thereby
03/26/2003EP1295893A1 SKIN TISSUE REGENERATION PROMOTERS COMPRISING GINSENOSIDE Rb1
03/26/2003EP1295670A2 Nondestructive inspection method
03/26/2003EP1295643A1 Liquid droplet ejecting method and a liquid droplet ejection apparatus
03/26/2003EP1295635A1 Pin plate for use in array printing and method for making the pin plate
03/26/2003EP1295610A2 Crystals of free and antibiotic complexed large ribosomal subunits
03/26/2003EP1295243A2 System for identifying clusters in scatter plots using smoothed polygons with optimal boundaries
03/26/2003EP1295131A2 Process for the measurement of non-transferrin bound iron
03/26/2003EP1295129A1 Differential diagnosis of neurological diseases
03/26/2003EP1295128A2 Rapid diagnostic method for distinguishing allergies and infections and nasal secretion collection unit
03/26/2003EP1295127A2 Inter-alpha-trypsin as a marker for sepsis
03/26/2003EP1295126A2 Hepatitis c viral antigen immunoassay detection systems
03/26/2003EP1295125A1 Immunological test and diagnostic kit for prostate adenocarcinoma
03/26/2003EP1295124A1 Competitive assay method
03/26/2003EP1295123A1 Selective labeling and isolation of phosphopeptides and applications to proteome analysis
03/26/2003EP1295122A2 Ipg assay
03/26/2003EP1295121A1 A bioluminescence resonance energy transfer (bret) system with broad spectral resolution between donor and acceptor emission wavelengths and its use
03/26/2003EP1295120A2 Agonist versus antagonist binding to g protein-coupled receptors
03/26/2003EP1295119A2 Scanning kelvin microprobe system and process for analyzing a surface
03/26/2003EP1295117A1 Sensor for helium or hydrogen
03/26/2003EP1295113A2 Non-thermosensitive medium for analysing species inside a channel
03/26/2003EP1295112A1 Positive identification of samples analysed by electrophoresis on a porous support
03/26/2003EP1295106A1 Non-dispersive ir measurement of gases using an optical filter
03/26/2003EP1295104A1 Method and apparatus for rapid fat content determination
03/26/2003EP1295091A1 Method for predicting flow properties of powders
03/26/2003EP1294952A1 Hiv-1 reporter viruses and their use in assaying anti-viral compounds
03/26/2003EP1294951A2 Diagnosis of diseases associated with the immune system
03/26/2003EP1294950A2 Diagnosis of diseases associated with development genes
03/26/2003EP1294949A2 Human tumor necrosis factor delta and epsilon
03/26/2003EP1294948A2 Diagnosis of behavioural disorders, neurological disorders and cancer
03/26/2003EP1294947A2 Method and nucleic acids for pharmacogenomic methylation analysis
03/26/2003EP1294945A2 Method for detecting cytosine methylations
03/26/2003EP1294944A2 Detection of nucleic acids by type-specific hybrid capture method
03/26/2003EP1294940A2 Polynucleotide probes for detection and quantitation of candida albicans and candida dubliniensis
03/26/2003EP1294931A1 Screening methods for gram-positive enterococcal virulence factors
03/26/2003EP1294930A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
03/26/2003EP1294928A1 Screening method for modulators of suv39h2-methyltransferase
03/26/2003EP1294927A1 Screening-method for modulators of methyltransferase-dependent chromosome stability
03/26/2003EP1294923A2 Methods for using mass spectrometry to identify and classify filamentous fungi, yeasts, molds and pollen
03/26/2003EP1294906A2 Whole-body optical imaging of gene expression and uses thereof
03/26/2003EP1294891A2 Transport peptides derived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof
03/26/2003EP1294888A2 Interferon-like protein zcyto21